Cardinal Health (CAH) to Divest Assets to Shanghai Pharma
Cardinal Health Inc. (CAH - Free Report) recently agreed to sell Cardinal Health China business to Shanghai Pharmaceuticals Holding Co. Ltd. for $1.2 billion. The sale includes Cardinal Health's pharmaceutical and medical products distribution business ...
Global External Fixator Market 2018 – B.Braun Melsungen AG , Cardinal Health
Global External Fixator Market Research Report 2018 provides a unique tool for evaluating the market, highlighting opportunities, and supporting strategic and tactical decision-making. This report recognizes that in this rapidly-evolving and ...
Shanghai Pharmaceuticals to Buy Cardinal Health's Unit for US$557 Million
Shanghai Pharmaceuticals Holding Co. (2607.HK) plans to buy the pharmaceutical distribution network of U.S. company Cardinal Health Inc. in Hong Kong and mainland China for US$557 million. The Hong Kong listed pharmaceutical company said ...